Steven Schow, PhD, has almost 40 years of pharmaceutical, biotech and agrichemical industrial R&D experience. His work in drug R&D spans a wide range of medical indications, including psychotropic, anti-infective, cardiovascular, metabolic, cancer and immunological diseases, as well research on novel insecticides.  He resume includes stints at Sterling Drug, DuPont Biochemicals, Wyeth. Dr. Schow was named as Telik’s Vice President of Chemistry Research in 2000, where he worked until retirement in 2014.